Application segmentation in the Brain Wave Detector market reveals distinct demand drivers. The Clinical Diagnostics segment dominates at 45% of market value, driven by EEG-based tools for epilepsy, sleep disorders, and traumatic brain injury assessments. Neurofeedback Therapy constitutes 30%, leveraging real-time brain activity monitoring for ADHD, PTSD, and cognitive rehabilitation. The Consumer Electronics segment, at 25%, reflects growing demand for wearable EEG headsets in gaming, meditation apps, and productivity tracking. These applications collectively shape Brain Wave Detector segmentation, with clinical use cases anchoring growth while consumer adoption fuels innovation in wearable technology. Market taxonomy underscores the clinical-to-consumer shift, balancing medical precision with accessibility.